| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium | 11 | 2015 | 60 | 3.660 |
Why?
|
| Leprosy | 7 | 2016 | 34 | 2.830 |
Why?
|
| Mycobacterium leprae | 6 | 2016 | 16 | 2.660 |
Why?
|
| Leprosy, Lepromatous | 5 | 2015 | 13 | 2.140 |
Why?
|
| Legionellosis | 4 | 2021 | 17 | 2.080 |
Why?
|
| RNA, Ribosomal, 16S | 18 | 2020 | 510 | 1.860 |
Why?
|
| Mycobacterium avium | 3 | 2020 | 21 | 1.420 |
Why?
|
| Sunlight | 2 | 2021 | 80 | 1.420 |
Why?
|
| Ultraviolet Rays | 2 | 2021 | 588 | 1.210 |
Why?
|
| Bacteremia | 11 | 2014 | 720 | 1.120 |
Why?
|
| Cytomegalovirus | 5 | 2012 | 496 | 1.050 |
Why?
|
| Sequence Analysis, DNA | 14 | 2020 | 2573 | 0.990 |
Why?
|
| Mycobacterium avium Complex | 3 | 2020 | 33 | 0.980 |
Why?
|
| Gram-Negative Bacterial Infections | 6 | 2010 | 170 | 0.860 |
Why?
|
| Mycobacterium Infections | 3 | 2007 | 49 | 0.830 |
Why?
|
| Legionella pneumophila | 1 | 2021 | 12 | 0.770 |
Why?
|
| Global Warming | 1 | 2021 | 5 | 0.770 |
Why?
|
| Cardiobacterium | 3 | 2005 | 3 | 0.760 |
Why?
|
| Catheterization, Central Venous | 5 | 2014 | 363 | 0.750 |
Why?
|
| DNA, Bacterial | 13 | 2015 | 606 | 0.720 |
Why?
|
| Hot Temperature | 1 | 2021 | 289 | 0.700 |
Why?
|
| Climate | 1 | 2019 | 25 | 0.690 |
Why?
|
| Cytomegalovirus Infections | 4 | 2010 | 494 | 0.690 |
Why?
|
| DNA, Ribosomal | 11 | 2015 | 104 | 0.660 |
Why?
|
| Temperature | 2 | 2019 | 538 | 0.620 |
Why?
|
| Virus Activation | 2 | 2012 | 236 | 0.610 |
Why?
|
| Infectious Mononucleosis | 2 | 2010 | 38 | 0.600 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 3 | 2013 | 86 | 0.580 |
Why?
|
| Polymerase Chain Reaction | 10 | 2020 | 3478 | 0.580 |
Why?
|
| Splenectomy | 2 | 2010 | 168 | 0.560 |
Why?
|
| Pseudomonas | 3 | 2011 | 23 | 0.550 |
Why?
|
| Legionella | 2 | 2016 | 18 | 0.540 |
Why?
|
| Endocarditis, Bacterial | 3 | 2010 | 152 | 0.520 |
Why?
|
| Molecular Sequence Data | 13 | 2015 | 6686 | 0.520 |
Why?
|
| Leprostatic Agents | 1 | 2015 | 4 | 0.520 |
Why?
|
| Phylogeny | 8 | 2015 | 867 | 0.510 |
Why?
|
| Pichia | 2 | 2006 | 60 | 0.490 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2014 | 11 | 0.490 |
Why?
|
| Pseudomonas Infections | 3 | 2011 | 166 | 0.480 |
Why?
|
| Abscess | 2 | 2007 | 192 | 0.480 |
Why?
|
| Fungemia | 2 | 2006 | 119 | 0.470 |
Why?
|
| Mouth | 2 | 2005 | 124 | 0.460 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2014 | 59 | 0.460 |
Why?
|
| Molecular Typing | 1 | 2014 | 55 | 0.450 |
Why?
|
| Blood | 4 | 2012 | 170 | 0.450 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 101 | 0.450 |
Why?
|
| Tuberculosis | 2 | 2014 | 613 | 0.440 |
Why?
|
| Immunocompromised Host | 3 | 2010 | 718 | 0.430 |
Why?
|
| Genes, Bacterial | 3 | 2020 | 270 | 0.430 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 2 | 2020 | 36 | 0.430 |
Why?
|
| Central Venous Catheters | 1 | 2014 | 100 | 0.430 |
Why?
|
| Species Specificity | 7 | 2014 | 794 | 0.410 |
Why?
|
| Viridans Streptococci | 2 | 2014 | 17 | 0.380 |
Why?
|
| Bacterial Typing Techniques | 5 | 2011 | 141 | 0.380 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 274 | 0.360 |
Why?
|
| Streptomyces | 2 | 2007 | 22 | 0.360 |
Why?
|
| Catheters, Indwelling | 4 | 2007 | 383 | 0.360 |
Why?
|
| Nontuberculous Mycobacteria | 2 | 2013 | 49 | 0.360 |
Why?
|
| Sepsis | 2 | 2014 | 686 | 0.360 |
Why?
|
| Humans | 72 | 2021 | 270631 | 0.360 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 408 | 0.340 |
Why?
|
| Adult | 32 | 2021 | 81946 | 0.330 |
Why?
|
| Microbial Sensitivity Tests | 9 | 2011 | 1072 | 0.330 |
Why?
|
| DNA Primers | 5 | 2020 | 1496 | 0.330 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2010 | 192 | 0.330 |
Why?
|
| Chromobacterium | 1 | 2008 | 1 | 0.320 |
Why?
|
| Lung Diseases | 2 | 2007 | 755 | 0.320 |
Why?
|
| Bacteriological Techniques | 4 | 2020 | 123 | 0.320 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2007 | 163 | 0.310 |
Why?
|
| Middle Aged | 33 | 2021 | 90294 | 0.310 |
Why?
|
| Neoplasms | 9 | 2015 | 15909 | 0.300 |
Why?
|
| Hemolysis | 1 | 2008 | 126 | 0.300 |
Why?
|
| Actinomycetales Infections | 2 | 2007 | 17 | 0.300 |
Why?
|
| RNA, Bacterial | 3 | 2007 | 84 | 0.300 |
Why?
|
| Aspergillosis | 4 | 2005 | 248 | 0.300 |
Why?
|
| Male | 40 | 2021 | 128316 | 0.290 |
Why?
|
| Antigens, Viral | 2 | 2007 | 520 | 0.290 |
Why?
|
| Xanthomonadaceae | 1 | 2006 | 2 | 0.290 |
Why?
|
| Gram-Positive Bacteria | 1 | 2007 | 68 | 0.280 |
Why?
|
| Aged | 28 | 2021 | 73338 | 0.280 |
Why?
|
| Genetic Variation | 1 | 2015 | 2165 | 0.280 |
Why?
|
| Neisseria | 1 | 2006 | 5 | 0.270 |
Why?
|
| Neisseriaceae Infections | 1 | 2006 | 4 | 0.270 |
Why?
|
| Aspergillus | 3 | 2005 | 151 | 0.270 |
Why?
|
| Seasons | 1 | 2007 | 338 | 0.260 |
Why?
|
| DNA Gyrase | 3 | 2014 | 26 | 0.260 |
Why?
|
| Campylobacter | 1 | 2005 | 29 | 0.250 |
Why?
|
| Meningoencephalitis | 1 | 2005 | 28 | 0.250 |
Why?
|
| Campylobacter Infections | 1 | 2005 | 42 | 0.250 |
Why?
|
| Fluoroquinolones | 2 | 2007 | 132 | 0.250 |
Why?
|
| Liver Abscess | 1 | 2005 | 37 | 0.250 |
Why?
|
| Tularemia | 1 | 2004 | 15 | 0.250 |
Why?
|
| Mexico | 2 | 2015 | 274 | 0.240 |
Why?
|
| Moraxellaceae Infections | 1 | 2004 | 3 | 0.240 |
Why?
|
| Pneumonia, Bacterial | 2 | 2016 | 135 | 0.240 |
Why?
|
| Peritonitis | 1 | 2004 | 98 | 0.230 |
Why?
|
| Aneurysm, Infected | 1 | 2004 | 29 | 0.230 |
Why?
|
| Female | 33 | 2021 | 148865 | 0.230 |
Why?
|
| Gram-Negative Aerobic Bacteria | 1 | 2003 | 5 | 0.230 |
Why?
|
| Fusobacterium Infections | 1 | 2003 | 30 | 0.220 |
Why?
|
| Opportunistic Infections | 1 | 2005 | 234 | 0.220 |
Why?
|
| Genes, rRNA | 3 | 2008 | 22 | 0.220 |
Why?
|
| Cytokines | 1 | 2012 | 2826 | 0.220 |
Why?
|
| Coinfection | 2 | 2015 | 200 | 0.210 |
Why?
|
| Fatal Outcome | 4 | 2012 | 824 | 0.210 |
Why?
|
| Intracranial Aneurysm | 1 | 2004 | 129 | 0.210 |
Why?
|
| Brain Abscess | 1 | 2003 | 74 | 0.210 |
Why?
|
| Viral Matrix Proteins | 3 | 2010 | 181 | 0.210 |
Why?
|
| Base Sequence | 4 | 2015 | 5437 | 0.210 |
Why?
|
| Helicobacter pylori | 2 | 2010 | 1434 | 0.210 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2015 | 334 | 0.200 |
Why?
|
| Postoperative Complications | 2 | 2010 | 5672 | 0.200 |
Why?
|
| Adolescent | 9 | 2021 | 32719 | 0.200 |
Why?
|
| Helicobacter Infections | 2 | 2010 | 1351 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 9 | 2013 | 3176 | 0.180 |
Why?
|
| Incidence | 3 | 2021 | 5821 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 4646 | 0.180 |
Why?
|
| Aged, 80 and over | 11 | 2016 | 30994 | 0.180 |
Why?
|
| Infant, Premature | 1 | 2006 | 843 | 0.180 |
Why?
|
| Granuloma | 1 | 2001 | 154 | 0.170 |
Why?
|
| Environmental Microbiology | 1 | 2019 | 22 | 0.170 |
Why?
|
| Urban Population | 1 | 2021 | 280 | 0.170 |
Why?
|
| Tissue Donors | 2 | 2010 | 815 | 0.160 |
Why?
|
| Antifungal Agents | 5 | 2006 | 880 | 0.160 |
Why?
|
| Fatty Acids | 3 | 2008 | 439 | 0.160 |
Why?
|
| Rural Population | 1 | 2021 | 292 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2005 | 1301 | 0.150 |
Why?
|
| Young Adult | 6 | 2021 | 22201 | 0.150 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 681 | 0.150 |
Why?
|
| Culture Media | 4 | 2006 | 343 | 0.150 |
Why?
|
| Public Health | 1 | 2019 | 296 | 0.140 |
Why?
|
| South America | 1 | 2016 | 54 | 0.140 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 4829 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 3603 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2019 | 1571 | 0.130 |
Why?
|
| Clofazimine | 1 | 2015 | 11 | 0.130 |
Why?
|
| Dapsone | 1 | 2015 | 15 | 0.130 |
Why?
|
| Sex Factors | 2 | 2014 | 2184 | 0.130 |
Why?
|
| Hematologic Neoplasms | 2 | 2010 | 1955 | 0.120 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2013 | 426 | 0.120 |
Why?
|
| Texas | 3 | 2015 | 6436 | 0.120 |
Why?
|
| Myanmar | 1 | 2014 | 9 | 0.120 |
Why?
|
| Malaysia | 1 | 2014 | 24 | 0.120 |
Why?
|
| Europe | 1 | 2016 | 657 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2015 | 1069 | 0.120 |
Why?
|
| Uganda | 1 | 2014 | 73 | 0.120 |
Why?
|
| Brazil | 1 | 2014 | 172 | 0.120 |
Why?
|
| Rifampin | 1 | 2015 | 218 | 0.120 |
Why?
|
| Child | 5 | 2021 | 30517 | 0.120 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 477 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2015 | 634 | 0.110 |
Why?
|
| United States | 2 | 2021 | 15834 | 0.110 |
Why?
|
| Prevalence | 2 | 2014 | 3401 | 0.110 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 48 | 0.100 |
Why?
|
| Anti-Infective Agents | 2 | 2007 | 466 | 0.100 |
Why?
|
| Biological Evolution | 1 | 2014 | 290 | 0.100 |
Why?
|
| Adenoviridae Infections | 1 | 2013 | 114 | 0.100 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 14616 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2021 | 17028 | 0.100 |
Why?
|
| Singapore | 1 | 2012 | 32 | 0.100 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2012 | 48 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2004 | 2330 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2021 | 8694 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 304 | 0.100 |
Why?
|
| Granuloma, Respiratory Tract | 1 | 2011 | 8 | 0.090 |
Why?
|
| Age Factors | 2 | 2014 | 5464 | 0.090 |
Why?
|
| Biofilms | 1 | 2013 | 205 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2012 | 110 | 0.090 |
Why?
|
| Genotype | 2 | 2014 | 4256 | 0.090 |
Why?
|
| Rhodobacteraceae | 1 | 2010 | 2 | 0.090 |
Why?
|
| Phosphoproteins | 2 | 2009 | 1137 | 0.090 |
Why?
|
| Developing Countries | 1 | 2013 | 340 | 0.090 |
Why?
|
| Amphotericin B | 3 | 2006 | 299 | 0.090 |
Why?
|
| Itraconazole | 3 | 2005 | 81 | 0.090 |
Why?
|
| Base Composition | 1 | 2009 | 93 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2012 | 1247 | 0.080 |
Why?
|
| Pseudogenes | 1 | 2009 | 91 | 0.080 |
Why?
|
| Cystitis | 1 | 2010 | 109 | 0.080 |
Why?
|
| BK Virus | 1 | 2010 | 126 | 0.080 |
Why?
|
| Hematologic Tests | 1 | 2009 | 84 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 7782 | 0.080 |
Why?
|
| Polyomavirus Infections | 1 | 2010 | 147 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2009 | 241 | 0.080 |
Why?
|
| Tumor Virus Infections | 1 | 2010 | 248 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 1558 | 0.080 |
Why?
|
| Skin | 2 | 2012 | 1273 | 0.080 |
Why?
|
| Encephalitis, Japanese | 1 | 1988 | 21 | 0.080 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 1988 | 26 | 0.080 |
Why?
|
| Streptococcal Infections | 2 | 2014 | 317 | 0.080 |
Why?
|
| Immunoglobulin M | 2 | 2005 | 359 | 0.070 |
Why?
|
| Sputum | 1 | 2008 | 157 | 0.070 |
Why?
|
| Lactobacillus plantarum | 1 | 2007 | 5 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2013 | 1497 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 2431 | 0.070 |
Why?
|
| Immunoglobulins | 1 | 1988 | 286 | 0.070 |
Why?
|
| Equipment Contamination | 1 | 2007 | 85 | 0.070 |
Why?
|
| Aspergillus fumigatus | 2 | 2005 | 136 | 0.070 |
Why?
|
| France | 1 | 2007 | 122 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2010 | 445 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2008 | 337 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2013 | 7017 | 0.070 |
Why?
|
| Bacterial Proteins | 2 | 2011 | 1093 | 0.070 |
Why?
|
| Nocardia | 1 | 2006 | 14 | 0.070 |
Why?
|
| Azithromycin | 1 | 2007 | 79 | 0.070 |
Why?
|
| Syndrome | 1 | 2010 | 1406 | 0.070 |
Why?
|
| Infant | 2 | 2021 | 13982 | 0.070 |
Why?
|
| Fluconazole | 2 | 2004 | 107 | 0.070 |
Why?
|
| Transplantation Conditioning | 2 | 2013 | 2368 | 0.070 |
Why?
|
| Mouth Mucosa | 1 | 2007 | 224 | 0.070 |
Why?
|
| Nocardia Infections | 1 | 2006 | 35 | 0.070 |
Why?
|
| Leukemia, Lymphoid | 1 | 2007 | 289 | 0.070 |
Why?
|
| Apgar Score | 1 | 2006 | 55 | 0.070 |
Why?
|
| Alleles | 1 | 2012 | 2590 | 0.070 |
Why?
|
| Lung Diseases, Fungal | 2 | 2005 | 132 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2010 | 2479 | 0.060 |
Why?
|
| DNA Topoisomerase IV | 1 | 2005 | 11 | 0.060 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 625 | 0.060 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2005 | 11 | 0.060 |
Why?
|
| Phenotype | 2 | 2008 | 6504 | 0.060 |
Why?
|
| Minocycline | 1 | 2007 | 189 | 0.060 |
Why?
|
| Sterols | 1 | 2005 | 21 | 0.060 |
Why?
|
| Gliotoxin | 1 | 2005 | 10 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 1 | 2006 | 173 | 0.060 |
Why?
|
| Hyphae | 1 | 2005 | 44 | 0.060 |
Why?
|
| Immunoglobulin G | 2 | 2005 | 1129 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 1312 | 0.060 |
Why?
|
| Dipeptides | 1 | 2005 | 96 | 0.060 |
Why?
|
| beta-Lactamases | 1 | 2007 | 223 | 0.060 |
Why?
|
| Methylobacteriaceae | 1 | 2004 | 1 | 0.060 |
Why?
|
| Azospirillum | 1 | 2004 | 1 | 0.060 |
Why?
|
| Moraxella | 1 | 2004 | 16 | 0.060 |
Why?
|
| Rupture, Spontaneous | 1 | 2004 | 69 | 0.060 |
Why?
|
| Plant Roots | 1 | 2004 | 45 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 5171 | 0.060 |
Why?
|
| Bronchitis | 1 | 2004 | 43 | 0.060 |
Why?
|
| Peptostreptococcus | 1 | 2003 | 7 | 0.060 |
Why?
|
| Bacteroides Infections | 1 | 2003 | 10 | 0.060 |
Why?
|
| Risk Factors | 3 | 2012 | 17875 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2012 | 1697 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2015 | 9290 | 0.060 |
Why?
|
| Cell Wall | 1 | 2003 | 51 | 0.060 |
Why?
|
| Gordonia Bacterium | 1 | 2003 | 2 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2007 | 380 | 0.050 |
Why?
|
| Stomatitis | 1 | 2004 | 193 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2006 | 2344 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 346 | 0.050 |
Why?
|
| Sinusitis | 1 | 2004 | 148 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2012 | 6238 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2006 | 580 | 0.050 |
Why?
|
| DNA, Fungal | 1 | 2003 | 144 | 0.050 |
Why?
|
| Medicine, Traditional | 1 | 2002 | 6 | 0.050 |
Why?
|
| Yogurt | 1 | 2002 | 8 | 0.050 |
Why?
|
| Candida | 1 | 2003 | 171 | 0.050 |
Why?
|
| Encephalitis | 1 | 2003 | 153 | 0.050 |
Why?
|
| West Nile virus | 1 | 2003 | 132 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 993 | 0.050 |
Why?
|
| Cholesterol | 1 | 2005 | 658 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 3027 | 0.050 |
Why?
|
| West Nile Fever | 1 | 2003 | 158 | 0.050 |
Why?
|
| Cross Infection | 1 | 2006 | 546 | 0.050 |
Why?
|
| Candidiasis | 1 | 2003 | 278 | 0.050 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 813 | 0.050 |
Why?
|
| Cryptococcosis | 1 | 2001 | 69 | 0.050 |
Why?
|
| Lung | 3 | 2011 | 3299 | 0.050 |
Why?
|
| Prosthesis-Related Infections | 1 | 2003 | 228 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 441 | 0.040 |
Why?
|
| Clostridium Infections | 1 | 2003 | 262 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2007 | 1414 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 1958 | 0.040 |
Why?
|
| Microbial Viability | 2 | 2012 | 64 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 6191 | 0.040 |
Why?
|
| Mycoses | 1 | 2003 | 393 | 0.040 |
Why?
|
| Neutrophils | 1 | 2004 | 873 | 0.040 |
Why?
|
| Probiotics | 1 | 2002 | 241 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2020 | 428 | 0.040 |
Why?
|
| Colony Count, Microbial | 2 | 2007 | 159 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 1366 | 0.030 |
Why?
|
| Animals | 5 | 2008 | 62031 | 0.030 |
Why?
|
| ADP Ribose Transferases | 1 | 1995 | 28 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2013 | 33722 | 0.030 |
Why?
|
| Exotoxins | 1 | 1995 | 76 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2013 | 3043 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 2014 | 25 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2013 | 39811 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 12024 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 1995 | 229 | 0.030 |
Why?
|
| Virulence Factors | 1 | 1995 | 233 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 4374 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1995 | 250 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2004 | 2808 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2007 | 1609 | 0.030 |
Why?
|
| 2-Propanol | 1 | 2012 | 8 | 0.030 |
Why?
|
| Disease Progression | 1 | 2004 | 6853 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2012 | 45 | 0.030 |
Why?
|
| Staphylococcus epidermidis | 1 | 2012 | 66 | 0.020 |
Why?
|
| Iodine | 1 | 2012 | 55 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2004 | 6766 | 0.020 |
Why?
|
| Phenazines | 1 | 2010 | 14 | 0.020 |
Why?
|
| Gentian Violet | 1 | 2010 | 23 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 206 | 0.020 |
Why?
|
| Plasmids | 2 | 2007 | 936 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2013 | 594 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 1642 | 0.020 |
Why?
|
| Microscopy | 1 | 2010 | 189 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 15204 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1359 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 2007 | 69 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1988 | 271 | 0.020 |
Why?
|
| Aza Compounds | 1 | 2007 | 25 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2010 | 727 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 7893 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 1121 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2020 | 3553 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2006 | 83 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 16204 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1988 | 1189 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 591 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2010 | 726 | 0.020 |
Why?
|
| Ergosterol | 1 | 2005 | 9 | 0.020 |
Why?
|
| Spores, Fungal | 1 | 2005 | 35 | 0.020 |
Why?
|
| Azoles | 1 | 2005 | 48 | 0.020 |
Why?
|
| Rhizoctonia | 1 | 2004 | 1 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 255 | 0.010 |
Why?
|
| Voriconazole | 1 | 2005 | 115 | 0.010 |
Why?
|
| Dog Diseases | 1 | 2005 | 76 | 0.010 |
Why?
|
| Aspergillus flavus | 1 | 2003 | 8 | 0.010 |
Why?
|
| Quinolines | 1 | 2007 | 403 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 417 | 0.010 |
Why?
|
| Aspergillus niger | 1 | 2003 | 27 | 0.010 |
Why?
|
| Scedosporium | 1 | 2003 | 24 | 0.010 |
Why?
|
| Fusarium | 1 | 2003 | 57 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 1160 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2003 | 243 | 0.010 |
Why?
|
| Autopsy | 1 | 2003 | 170 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 661 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 269 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 607 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2010 | 2438 | 0.010 |
Why?
|
| Lactobacillus | 1 | 2002 | 59 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 10383 | 0.010 |
Why?
|
| Yeasts | 1 | 2002 | 76 | 0.010 |
Why?
|
| Device Removal | 1 | 2004 | 338 | 0.010 |
Why?
|
| Zea mays | 1 | 2002 | 51 | 0.010 |
Why?
|
| Symbiosis | 1 | 2002 | 76 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 878 | 0.010 |
Why?
|
| Peptides | 1 | 2007 | 1504 | 0.010 |
Why?
|
| Triazoles | 1 | 2005 | 627 | 0.010 |
Why?
|
| Catheterization | 1 | 2003 | 417 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 792 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2002 | 628 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 6397 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 3447 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 7097 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1995 | 146 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 1995 | 69 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 453 | 0.010 |
Why?
|
| Mice | 2 | 2007 | 35586 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 14833 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 219 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1995 | 665 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2005 | 3666 | 0.010 |
Why?
|